AL
TMO icon

Aspiriant LLC’s Thermo Fisher Scientific TMO Stock Holding History

Aspiriant LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Sell
1,212
-198
-14% -$107K 0.02% 197
2025
Q4 		$817K Sell
1,410
-207
-13% -$117K 0.02% 171
2025
Q3 		$784K Sell
1,617
-11
-0.7% -$5.12K 0.02% 167
2025
Q2 		$660K Sell
1,628
-63
-4% -$26.3K 0.02% 177
2025
Q1 		$841K Buy
1,691
+23
+1% +$12.5K 0.03% 150
2024
Q4 		$868K Buy
1,668
+43
+3% +$23.6K 0.03% 151
2024
Q3 		$1.01M Buy
1,625
+154
+10% +$91.2K 0.04% 144
2024
Q2 		$813K Sell
1,471
-354
-19% -$203K 0.03% 156
2024
Q1 		$1.06M Sell
1,825
-17
-0.9% -$9.54K 0.04% 142
2023
Q4 		$978K Sell
1,842
-173
-9% -$83.7K 0.04% 147
2023
Q3 		$1.02M Buy
2,015
+179
+10% +$95.4K 0.05% 132
2023
Q2 		$958K Buy
1,836
+1
+0.1% +$540 0.05% 139
2023
Q1 		$1.06M Sell
1,835
-25
-1% -$14.1K 0.06% 128
2022
Q4 		$1.02M Buy
1,860
+276
+17% +$146K 0.05% 130
2022
Q3 		$805K Buy
1,584
+101
+7% +$56.5K 0.04% 132
2022
Q2 		$805K Buy
1,483
+16
+1% +$8.81K 0.04% 137
2022
Q1 		$866K Sell
1,467
-42
-3% -$24.1K 0.05% 143
2021
Q4 		$1.01M Buy
1,509
+22
+1% +$13.7K 0.05% 132
2021
Q3 		$849K Sell
1,487
-72
-5% -$39.5K 0.05% 127
2021
Q2 		$786K Sell
1,559
-52
-3% -$24.5K 0.04% 131
2021
Q1 		$735K Buy
1,611
+19
+1% +$9.07K 0.05% 124
2020
Q4 		$741K Buy
1,592
+54
+4% +$25.3K 0.05% 124
2020
Q3 		$681K Buy
1,538
+8
+0.5% +$3.31K 0.05% 130
2020
Q2 		$554K Buy
+1,530
New +$513K 0.05% 125
2019
Q3 		– Sell
-745
Closed -$219K – 229
2019
Q2 		$219K Hold
745
– – 0.02% 210
2019
Q1 		$204K Sell
745
-264
-26% -$65.7K 0.02% 220
2018
Q4 		$225K Buy
+1,009
New +$237K 0.02% 211
2018
Q2 		– Sell
-992
Closed -$205K – 262
2018
Q1 		$205K Buy
+992
New +$208K 0.02% 229

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Aspiriant LLC's TMO Position: Q1 2026 in Review

Aspiriant LLC reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, selling an estimated $107K and leaving 1,212 shares worth $596K. The position accounts for 0.02% of the portfolio, ranked #197.

Aspiriant LLC first reported a position in TMO in Q1 2018 and has held it in 28 quarters since. The position peaked at $1.06M in Q1 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Aspiriant LLC held 1,212 shares of Thermo Fisher Scientific worth $596K as of Q1 2026.
  • Aspiriant LLC sold 198 Thermo Fisher Scientific shares in Q1 2026, an estimated $107K.
  • Thermo Fisher Scientific made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #197 holding.
  • Aspiriant LLC first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 28 quarters since.
  • Aspiriant LLC's Thermo Fisher Scientific position peaked at $1.06M in Q1 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.